Novo Nordisk To Challenge Russian Competition Fine
Novo Nordisk A/S is planning to challenge a decision by Russia's competition authority to fine the insulin maker for allegedly limiting competition in the pharmaceutical market....To view the full article, register now.
Already a subscriber? Click here to view full article